A pan-variant T-cell vaccine component broadens immunity and protects against severe COVID-19 in a preclinical model in combination with BNT162b2

ABSTRACT: Targeted mass spectrometry analysis on HLA-presented epitopes derived from the SARS-CoV-2 T cell vaccine candidate BNT162b4

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Asaf Poran  

PROVIDER: MSV000091008 | MassIVE | Wed Jan 04 15:12:00 GMT 2023

REPOSITORIES: MassIVE